Beckman Coulter acquires Blue Ocean Medical
Deal expands flow cytometry systems and reagents product line
Beckman Coulter Life Sciences, a division of biomedical testing specialist Beckman Coulter, has acquired Blue Ocean Biomedical, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents.
The deal provides Beckman Coulter Life Sciences, based in Brea, California, with low complexity analysers that integrate automated sample preparation and address emerging flow cytometry market trends.
Beckman Coulter Life Sciences says Blue Ocean Biomedical’s products complement its cytometry portfolio with instruments based on a ‘sample in, result out’ (SIRO) approach. They will enable the firm to deliver an expanded portfolio to a broader market globally.
‘This acquisition provides both immediate opportunity and long-term value,’ said Scott Atkin, president, Beckman Coulter Life Sciences.
‘The simplification of customer workflows will be dramatic. We’ll be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry.’
Mike Brochu, ceo and co-founder of Blue Ocean Biomedical, said: ‘Our team has developed a line of unique instrument systems: essentially, the world’s first ‘load & go’ flow cytometers.’
The Blue Ocean Biomedical systems and reagents are currently available for distribution only in the European Union.
